Snowden Capital Advisors LLC Phase Bio Pharmaceuticals Inc Transaction History

Snowden Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.52 - $1.59 $4,680 - $14,310	9,000 Added 17.37%	60,800 $36,000
Q1 2022 May 16, 2022	BUY	$0.97 - $2.66 $22,310 - $61,180	23,000 Added 79.86%	51,800 $68,000
Q4 2021 Feb 14, 2022	BUY	$1.9 - $4.05 $54,720 - $116,640	28,800 New	28,800 $75,000
Q3 2021 Feb 05, 2024	BUY	$2.72 - $3.85 $57,120 - $80,850	21,000 New	21,000 $65.3 Million
Q1 2021 Jan 08, 2024	BUY	$3.25 - $5.55 $65,000 - $111,000	20,000 New	20,000 $69.2 Million

Ticker PHAS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,858,100
Description
PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiovascular diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical trial for patients with uncontrolled major or li...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.